Morgenthaler; Nils

Patent Applications and Registrations

Patent applications and USPTO patent grants for Morgenthaler; Nils.The latest application filed is for "diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin ii".

Company Profile

2.17.19

Morgenthaler; Nils - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II Grant 10,718,783 - Bergmann , et al.	2020-07-21
In vitro method for early or differential diagnosis or prognosis of myocardial infarction in a patient Grant 10,254,289 - Bergmann , et al.	2019-04-09
Prognosis and risk assessment in stroke patients by determining the level of marker peptides Grant 10,067,063 - Bergmann , et al. September 4, 2	2018-09-04
Diagnosis And Risk Stratification Of Infections And Chronic Diseases Of The Respiratory Tract And Lungs By Means Of Provasopressin, Particularly Copeptin Or Neurophysin Ii App 20170059583 - BERGMANN; Andreas ; et al.	2017-03-02
Diagnosis and Risk Assessment of Pancreatic Diabetes Using MR-proADM App 20160169912 - Bergmann; Andreas ; et al.	2016-06-16
Risk Stratification for Acute Coronary Syndrome by Means of Fragments/Partial Peptides of Provasopressin, Especially Copeptin or Neurophysin II App 20160131660 - Bergmann; Andreas ; et al.	2016-05-12
Diagnosis of acute coronary syndrome, myocardial infarction, or angina pectoris by means of neurophysin II Grant 9,261,517 - Bergmann , et al. February 16, 2	2016-02-16
Methods Of Diagnosis And Risk Stratification Of Adverse Events In Post Myocardial Infarction Patients Using Pro-adrenomedullin App 20150192595 - NG; LEONG L. ; et al.	2015-07-09
Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using pro-adrenomedullin Grant 9,012,151 - Ng , et al. April 21, 2	2015-04-21
Method for determining amino-terminal proANP in patients having a cardiac disease or being suspected of developing or having a cardiac disease Grant 8,647,830 - Bergmann , et al. February 11, 2	2014-02-11
Prognosis And Risk Assessment In Stroke Patients By Determining The Level Of Marker Peptides App 20140017808 - BERGMANN; Andreas ; et al.	2014-01-16
Risk Stratification For Acute Coronary Syndrome By Means Of Fragments/partial Peptides Of Provasopressin, Especially Copeptin Or Neurophysin Ii App 20130344513 - Bergmann; Andreas ; et al.	2013-12-26
Diagnosis and risk classification of acute coronary syndrome by means of CT-proET-1 in combination with NT-proBNP Grant 8,524,463 - Bergmann , et al. September 3, 2	2013-09-03
Risk stratification for acute coronary syndrome by determining copeptin Grant 8,501,485 - Bergmann , et al. August 6, 2	2013-08-06
Procalcitonin-based diagnosis of infections or inflammatory diseases of the respiratory tract in a patient with heart failure Grant 8,465,941 - Bergmann , et al. June 18, 2	2013-06-18
Diagnosis And Risk Stratification Of Infections And Chronic Diseases Of The Respiratory Tract And Lungs By Means Of Provasopressin, Particularly Copeptin Or Neurophysin Ii App 20120270245 - Bergmann; Andreas ; et al.	2012-10-25
Diagnosis and risk stratification of cardiac insufficiency by means of natriuretic peptides for NYHA I patients Grant 8,252,544 - Bergmann , et al. August 28, 2	2012-08-28
Diagnosis and risk stratification of infections and chronic diseases of the respiratory tract and lungs by means of provasopressin, particularly copeptin or neurophysin II Grant 8,158,368 - Bergmann , et al. April 17, 2	2012-04-17
Prognosis And Risk Assessment In Stroke Patients By Determining The Level Of Marker Peptides App 20110263821 - Bergmann; Andreas ; et al.	2011-10-27
Azurophilic Granule Proteases As Markers In Cardiological Diseases App 20110229911 - Bergmann; Andreas ; et al.	2011-09-22
Pro-endothelin-1 Levels For The Prediction Of Risk Of Tachyarrhytmic Events App 20110111525 - Struck; Joachim ; et al.	2011-05-12
Pro-endothelin-1 For The Prediction Of Impaired Peak Oxygen Consumption App 20110111526 - Struck; Joachim ; et al.	2011-05-12
Method For Determining Amino-terminal Proanp In Patients Having A Cardiac Disease Or Being Suspected Of Developing Or Having A Cardiac Disease App 20100285493 - Bergmann; Andreas ; et al.	2010-11-11
Diagnosis And Risk Classification Of Acute Coronary Syndrome By Means Of Ct-proet-1 In Combination With Nt-probnp App 20100151504 - Bergmann; Andreas ; et al.	2010-06-17
Diagnosis And Risk Stratification Of Cardiac Insufficiency By Means Of Natriuretic Peptides For Nyha I Patients App 20100143953 - Bergmann; Andreas ; et al.	2010-06-10
Diagnosis Of Infections Or Inflammatory Diseases Of The Airways And Lungs Associated With Heart Failure App 20100047835 - Bergmann; Andreas ; et al.	2010-02-25
Diagnosis And Risk Stratification Of Infections And Chronic Diseases Of The Respiratory Tract And Lungs By Means Of Provasopressin, Particularly Copeptin Or Neurophysin Ii App 20100041064 - Bergmann; Andreas ; et al.	2010-02-18
Diagnosis And Risk Assessment Of Pancreatic Diabetes Using Mr-proadm App 20100035275 - Bergmann; Andreas ; et al.	2010-02-11
Risk Stratification For Acute Coronary Syndrome By Means Of Fragments/partial Peptides Of Provasopressin, Especially Copeptin Or Neurophysin Ii App 20100028921 - Bergmann; Andreas ; et al.	2010-02-04
Methods of Diagnosis and Risk Stratification of Adverse Events in Post Myocardial Infarction Patients Using Pro-adrenomedullin App 20080213746 - Ng; Leong Loke ; et al.	2008-09-04
Receptor binding assays and reagent kit for detecting TSH receptor autoantibodies Grant 7,015,003 - Bergmann , et al. March 21, 2	2006-03-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.